About Company

AlphaLife Sciences is an AI-native platform company transforming how therapies move from lab to market. AuroraPrime supports nonclinical, clinical, CMC, safety, labeling, and post-market documentation across the drug lifecycle, accelerating IND, NDA, BLA, and MAA filings for pharmaceutical companies, biotech firms, and CROs.
AuroraPrime combines document-specific depth and quality, proven across complex deliverables; a connected workflow spanning authoring, evidence, logic, quality control, and review; and integrated eCTD coverage that keeps documents, content, and evidence aligned across the dossier. Its embedded AI agents support authoring, quality control, and cross-functional review within life sciences workflows.
The team includes talent from Google, Microsoft, Veeva, Medidata, and McKinsey, with guidance from former FDA officials and senior pharmaceutical executives. Strategic partners include NVIDIA, Veeva, and Johnson & Johnson Innovation JLABS. Validated as Microsoft’s strategic AI content-authoring partner for life sciences, AuroraPrime is trusted by more than half of the world’s top 20pharmaceutical companies.

Vision, Mission, and Key Pillar Products

Our Vision is to accelerate global drug development—making it faster and more affordable through AI. Our Mission is to automate life-science content authoring and insight generation with AI, enabling biopharma teams to achieve greater efficiency, quality, and compliance. Our four pillar product lines, in both production and roadmap, are delivered through the AuroraPrime suite—a scalable, hyperscaler-powered GenAI platform built on Content Authoring, Content Insights, an AI Platform for Developers, and 360° Clinical Efficiency—together enabling true end-to-end drug lifecycle transformation.

Our Vision

Revolutionizing Life Sciences with Generative AI:

Accelerating Faster, Affordable Drug Development.

Vision

Leadership Team

Sharon Chen

Sharon Chen

CEO
Former Director of Google R&D; Former General Manager of Verily APAC
Gavin Zhang

Gavin Zhang

Chief Business Officer
Former Head of Channel Sales Asia Pacific of Medidata; Former Key Account Solution Sales at Microsoft
Bogong Zhu

Bogong Zhu

Chief Product Officer
Former Senior Technical Supervisor at Google & Verily
Pengcheng Xu

Pengcheng Xu

Chief Technology Officer
Engineering Lead at Google; Former Engineering Architect at Verily

Advisory Board

Judy Kannenberg

Judy Kannenberg

Former Vice President, Regulatory Affairs Head, BioPharma, CCDS & Labeling, and Regulatory Affairs Therapeutic Area Head, Astellas; Senior Manager, Global Regulatory Affairs, Baxter.
Karen Devcich

Karen Devcich

Former Vice President, Medical Writing, Quality & Editing and Clinical Trial Transparency, ICON; Former Vice President, Global Medical Writing, Takeda.
Zhenming Shun

Zhenming Shun

Former Vice President, Head of Statistics and Data Management, Daiichi Sankyo; Former Global Head of Statistics, Oncology, Sanofi; Senior Research Statistician, Bristol-Myers Squibb.
Jean-Marie Geoffroy

Jean-Marie Geoffroy

Former Vice President, Sterile Injectables Design, Pfizer; Former Director & Senior Fellow, Takeda; Former Director & Research Investigator, Abbott.
Kun He

Kun He

Former CEO and Chief Statistician, R&G; Former Associate Division Director and Master Reviewer, Office of Biostatistics, CDER, FDA.

Brand Story

In 2020, a group of senior technology and product experts from Google and Verily decided to start a business and delve into the intelligent digitalization of life science clinical research. With the goal of building a SaaS platform for life science and consumer health fields through world-leading computer technology, AlphaLife Sciences was officially established in August 2020. With the vision of "Use technology to advance innovation in life science and consumer health. Faster, more accessible and evidence-based," the AlphaLife team quickly grew and attracted many technology talents from leading global IT companies and senior industry experts from the life sciences field. With the gradual launch of AlphaLife's innovative products, more and more leading life science innovation and development companies, as well as ecosystem partners, choose AlphaLife, collaborate in multiple ways, and jointly explore the future of intelligent digitalization in clinical research.

Our global network and support

With experienced staff and trusted partners worldwide, we provide comprehensive support to ensure you have the resources you need, wherever you are.
Map
  • New Jersey

  • San Francisco

  • Philadelphia

  • Singapore

  • Switzerland

  • Shanghai